TRITTO, VIVIANA
TRITTO, VIVIANA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Genetic/epigenetic effects in NF1 microdeletion syndrome: beyond the haploinsufficiency, looking at the contribution of not deleted genes
2024 V. Tritto, P. Bettinaglio, E. Mangano, C. Cesaretti, F. Marasca, C. Castronovo, R. Bordoni, C. Battaglia, V. Saletti, V. Ranzani, B. Bodega, M. Eoli, F. Natacci, P. Riva
Expression analysis of NF1-mutated alleles in a rare compound heterozygous spinal NF1 patient by digital PCR
2024 P. Bettinaglio, V. Tritto, R. Paterra, M. Eoli, P. Riva
New insights into the molecular basis of spinal neurofibromatosis type 1
2023 P. Bettinaglio, E. Mangano, V. Tritto, R. Bordoni, R. Paterra, A. Borghi, M. Volontè, C. Battaglia, V. Saletti, C. Cesaretti, F. Natacci, M.A.B. Melone, M. Eoli, P. Riva
A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort
2023 R. Paterra, P. Bettinaglio, A. Borghi, E. Mangano, V. Tritto, C. Cesaretti, C. Schettino, R. Bordoni, C. Santoro, S. Avignone, M.E.M. Moscatelli, M. Anna Beatrice Melone, V. Saletti, G. Piluso, F. Natacci, P.V. Riva, M. Eoli
Deregulated expression of polycomb repressive complex 2 target genes in a NF1 patient with microdeletion generating the RNF135-SUZ12 chimeric gene
2023 V. Tritto, F. Grilli, D. Milani, P.V. Riva
Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes
2023 V. Tritto, D. Capitanio, C. Gelfi, P. Riva
Role of hypomorphic variants in variable expressivity of Noonan syndrome
2022 V. Tritto, E. Mangano, M.T. Bonati, P. Bettinaglio, C. Battaglia, R. Bordoni, P. Riva
Preclinical and clinical evidence on the approach-avoidance conflict evaluation as an integrative tool for psychopathology
2022 F. Rusconi, M.G. Rossetti, C. Forastieri, V. Tritto, M. Bellani, E. Battaglioli
Position effect and of modifier Ras pathway genes in Neurofibromatosis type I microdeletion syndrome
2022 P. Bettinaglio, V. Tritto, E. Mangano, R. Bordoni, C. Castronuovo, M. Volontè, C. Cesaretti, G.A. Cagnoli, C. Battaglia, V. Saletti, D. Bianchessi, F. Natacci, M. Eoli, P. Riva
Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes
2022 V. Tritto, M. Eoli, R. Paterra, S. Redaelli, M. Moscatelli, F. Rusconi, P. Riva
NF1 Gene Mutation Mediates Neuronal Signaling De-Regulation Triggering Pediatric Optic Glioma Development: Another Small Step towards a Cure of NF1 Disorder?
2021 P. Riva, V. Tritto
Prevalence of NF1 missense mutations and candidate modifier genes in 12 familial and 15 sporadic spinal neurofibromatosis patients
2020 P. Riva, E. Mangano, C. Cesaretti, P. Bettinaglio, R. Bordoni, V. Tritto, C. Battaglia, V. Saletti, D. Bianchessi, M. Marina Melone, C. Schettino, F. Natacci, M. Eoli
Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients
2019 V. Tritto, L. Ferrari, S. Esposito, P. Zuccotti, D. Bianchessi, F. Natacci, V. Saletti, M. Eoli, P. Riva